CN114042478B - 一种光响应横向过滤芯片及单个癌细胞的分离与释放方法 - Google Patents
一种光响应横向过滤芯片及单个癌细胞的分离与释放方法 Download PDFInfo
- Publication number
- CN114042478B CN114042478B CN202111331531.5A CN202111331531A CN114042478B CN 114042478 B CN114042478 B CN 114042478B CN 202111331531 A CN202111331531 A CN 202111331531A CN 114042478 B CN114042478 B CN 114042478B
- Authority
- CN
- China
- Prior art keywords
- chip
- micro
- main channel
- channel
- capture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 31
- 201000011510 cancer Diseases 0.000 title claims abstract description 28
- 238000001914 filtration Methods 0.000 title claims abstract description 19
- 238000000926 separation method Methods 0.000 title description 7
- 239000000463 material Substances 0.000 claims abstract description 53
- 239000000758 substrate Substances 0.000 claims abstract description 35
- 238000012216 screening Methods 0.000 claims abstract description 20
- 238000005286 illumination Methods 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 21
- 239000006285 cell suspension Substances 0.000 claims description 19
- -1 N, N-dimethylamino Chemical group 0.000 claims description 18
- 230000009471 action Effects 0.000 claims description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 238000003491 array Methods 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 239000000155 melt Substances 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 6
- 239000002861 polymer material Substances 0.000 claims description 6
- 229910052710 silicon Inorganic materials 0.000 claims description 6
- 239000010703 silicon Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 230000002427 irreversible effect Effects 0.000 claims description 4
- 238000002715 modification method Methods 0.000 claims description 4
- 229920000089 Cyclic olefin copolymer Polymers 0.000 claims description 3
- 239000004713 Cyclic olefin copolymer Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000003575 carbonaceous material Substances 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 claims description 3
- 229960004657 indocyanine green Drugs 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000007769 metal material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000178 monomer Substances 0.000 claims description 3
- 229910000510 noble metal Inorganic materials 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 239000000123 paper Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 3
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 3
- 229920000193 polymethacrylate Polymers 0.000 claims description 3
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 3
- 239000004800 polyvinyl chloride Substances 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 3
- 238000004080 punching Methods 0.000 claims description 3
- 239000003431 cross linking reagent Substances 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 1
- 125000005395 methacrylic acid group Chemical group 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 75
- 210000005266 circulating tumour cell Anatomy 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 6
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000004298 light response Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000008204 material by function Substances 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101710134784 Agnoprotein Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229910021389 graphene Inorganic materials 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000002601 intratumoral effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 229920002246 poly[2-(dimethylamino)ethyl methacrylate] polymer Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003320 cell separation method Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- XQSBLCWFZRTIEO-UHFFFAOYSA-N hexadecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[NH3+] XQSBLCWFZRTIEO-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000001001 laser micro-dissection Methods 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111331531.5A CN114042478B (zh) | 2021-11-11 | 2021-11-11 | 一种光响应横向过滤芯片及单个癌细胞的分离与释放方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111331531.5A CN114042478B (zh) | 2021-11-11 | 2021-11-11 | 一种光响应横向过滤芯片及单个癌细胞的分离与释放方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114042478A CN114042478A (zh) | 2022-02-15 |
CN114042478B true CN114042478B (zh) | 2023-03-21 |
Family
ID=80208351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111331531.5A Active CN114042478B (zh) | 2021-11-11 | 2021-11-11 | 一种光响应横向过滤芯片及单个癌细胞的分离与释放方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114042478B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114606128A (zh) * | 2022-04-01 | 2022-06-10 | 中睿芯康(南京)生物科技有限公司 | 光热材料集成药物可控释放微流控器官芯片系统及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148543A1 (en) * | 2002-02-04 | 2003-08-07 | Fuji Photo Film Co., Ltd. | Method for conducting receptor-ligand association reaction |
US20170225166A1 (en) * | 2014-08-07 | 2017-08-10 | The General Hospital Corporation | Platelet-Targeted Microfluidic Isolation of Cells |
CN112718027A (zh) * | 2020-12-10 | 2021-04-30 | 上海市东方医院(同济大学附属东方医院) | 微流控芯片和温敏材料复合系统及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008136475A (ja) * | 2006-11-10 | 2008-06-19 | Univ Waseda | 細胞捕捉装置及びそれを利用した細胞操作方法 |
CN105462812B (zh) * | 2015-12-11 | 2017-09-19 | 武汉纺织大学 | 一种基于石蜡衬底膜的细胞捕获与释放芯片的制备方法 |
CN108753571A (zh) * | 2018-05-30 | 2018-11-06 | 上海交通大学医学院附属仁济医院 | 一种细胞分型捕获芯片及方法 |
CN113145192B (zh) * | 2021-05-28 | 2022-06-07 | 哈尔滨工业大学(深圳) | 基于气动阀门打印单个微粒的微流控芯片和方法 |
-
2021
- 2021-11-11 CN CN202111331531.5A patent/CN114042478B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148543A1 (en) * | 2002-02-04 | 2003-08-07 | Fuji Photo Film Co., Ltd. | Method for conducting receptor-ligand association reaction |
US20170225166A1 (en) * | 2014-08-07 | 2017-08-10 | The General Hospital Corporation | Platelet-Targeted Microfluidic Isolation of Cells |
CN112718027A (zh) * | 2020-12-10 | 2021-04-30 | 上海市东方医院(同济大学附属东方医院) | 微流控芯片和温敏材料复合系统及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN114042478A (zh) | 2022-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107012067B (zh) | 一种高通量配对捕获单细胞/单颗粒的微流控芯片及其应用 | |
Luan et al. | Microfluidic systems for hydrodynamic trapping of cells and clusters | |
US8372657B2 (en) | Microfluidic system for detecting a biological entity in a sample | |
Wu et al. | Microfluidic technologies in cell isolation and analysis for biomedical applications | |
WO2019128841A1 (zh) | 一种螺旋形微通道及其使用方法与串、并联安装结构 | |
CN105848793A (zh) | 材料选择性的递送至细胞 | |
CN107583676A (zh) | 一种微流控芯片及外泌体捕获和检测的研究方法 | |
CN114042478B (zh) | 一种光响应横向过滤芯片及单个癌细胞的分离与释放方法 | |
CN109913352B (zh) | 一种基于非接触式介电电泳力操控捕获微颗粒和细胞的微流控装置及方法 | |
CN107828651A (zh) | 一种用于单细胞微液滴样品制备的微流控芯片 | |
CN101168717A (zh) | 一种用于细胞凋亡研究的集成化微流控芯片及其应用 | |
US11358147B2 (en) | System and method for isolating and analyzing cells | |
CN104111190A (zh) | 一种双螺旋微流控芯片 | |
CN108117968A (zh) | 一种基于液滴微流控芯片的高通量自动捕获单细胞的方法 | |
CN108535228A (zh) | 一种从孕妇外周血中分离游离胎儿细胞的方法 | |
He et al. | State-of-the-arts techniques and current evolving approaches in the separation and detection of circulating tumor cell | |
JP6839173B2 (ja) | 流体力学シャトリングチップ機器、及び、分離した単一細胞を捕捉する方法 | |
US9975125B2 (en) | Microsieve diagnostic device in the isolation and analysis of single cells | |
TWM583456U (zh) | 具有珠體繫留結構的微流道晶片及微流道結構 | |
CN210230002U (zh) | 微流道芯片以及微流道结构 | |
CN104513798B (zh) | 一种用于微量细胞培养的微流控芯片 | |
TWM583855U (zh) | 具有不平整結構的微流道晶片及微流道結構 | |
CN112080420A (zh) | 微囊泡的分离方法及设备 | |
TWM581591U (zh) | 具有小孔徑緩流區段的微流道晶片及微流道結構 | |
TWM583455U (zh) | 具有增阻區段的微流道晶片及微流道結構 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20220215 Assignee: Jiangsu Gongwei Electronic Technology Co.,Ltd. Assignor: CHANGZHOU University Contract record no.: X2023980053014 Denomination of invention: A Light responsive Lateral Filter Chip and Separation and Release Method for Single Cancer Cells Granted publication date: 20230321 License type: Common License Record date: 20231220 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20220215 Assignee: Changzhou Ruixinteng Microelectronics Co.,Ltd. Assignor: CHANGZHOU University Contract record no.: X2023980054127 Denomination of invention: A Light responsive Lateral Filter Chip and Separation and Release Method for Single Cancer Cells Granted publication date: 20230321 License type: Common License Record date: 20231227 |
|
EE01 | Entry into force of recordation of patent licensing contract |